Cystatin C concentration as a predictor of systolic and diastolic heart failure

被引:78
作者
Moran, Andrew [1 ,2 ]
Katz, Ronit
Smith, Nicolas L. [3 ]
Fried, Linda F. [4 ]
Sarnak, Mark J. [5 ]
Seliger, Stephen L. [6 ]
Psaty, Bruce [3 ]
Siscovick, David S. [3 ]
Gottdiener, John S. [7 ]
Shlipak, Michael G. [1 ,2 ]
机构
[1] Vet Adm Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA
[4] Vet Affairs Pittsburgh Healthcare Syst, Renal Sect, Med Serv, Pittsburgh, PA USA
[5] Tufts Univ New England Med Ctr, Boston, MA USA
[6] Univ Maryland, Baltimore, MD 21201 USA
[7] Univ Maryland, Sch Med, Div Cardiol, Baltimore, MD 21201 USA
关键词
cystatin C; diastolic heart failure; ejection fraction; elderly; estimated glomerular filtration rate; heart failure; systolic heart failure;
D O I
10.1016/j.cardfail.2007.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Risk factors for heart failure (HF) may differ according to ejection fraction (EF). Higher cystatin C, a marker of kidney dysfunction, is associated with incident HF, but previous studies did not determine EF at diagnosis. We hypothesized that kidney dysfunction would predict diastolic HF (DHF) better than systolic HF (SHF) in the Cardiovascular Health Study. Methods and Results: Cystatin C was measured in 4453 participants without HF at baseline. Incident HF was categorized as DHF (EF >= 50%) or SHF (EF < 50%). We compared the association of cystatin C with the risk for DHF and SHE after adjustment for age, sex, race, medications, and HF risk factors. During 8 years of follow-up, 167 participants developed DHF and 206 participants developed SHE After adjustment, sequentially higher quartiles of cystatin C were associated with risk for SHF (competing risks hazard ratios 1.0 [reference], 1.99 [95% confidence interval 1.14-3.48], 2.32 [1.32-4.07], 3.17 [1.82-5.50], P for trend < .001). The risk for DHF was apparent only at the highest cystatin C quartile (hazard ratios 1.0 [reference], 1.09 [0.62-1.89], 1.08 [0.61-1.93], and 1.83 [1.07-3.11]). Conclusions: Cystatin C levels are linearly associated with the incidence of systolic HF, whereas only the highest concentrations of cystatin C predict diastolic HF.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 40 条
[1]   Outcome of heart failure with preserved ejection fraction in a population-based study [J].
Bhatia, R. Sacha ;
Tu, Jack V. ;
Lee, Douglas S. ;
Austin, Peter C. ;
Fang, Jiming ;
Haouzi, Annick ;
Gong, Yanyan ;
Liu, Peter P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (03) :260-269
[2]   Predictors of heart failure among women with coronary disease [J].
Bibbins-Domingo, K ;
Lin, F ;
Vittinghoff, E ;
Barrett-Connor, E ;
Hulley, SB ;
Grady, D ;
Shlipak, MG .
CIRCULATION, 2004, 110 (11) :1424-1430
[3]   Renal function and heart failure risk in older black and white individuals - The health, aging, and body composition study [J].
Bibbins-Domingo, Kirsten ;
Chertow, Glenn M. ;
Fried, Linda F. ;
Odden, Michelle C. ;
Newman, Anne B. ;
Kritchevsky, Stephen B. ;
Harris, Tamara B. ;
Satterfield, Suzanne ;
Cummings, Steven R. ;
Shlipak, Michael G. .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (13) :1396-1402
[4]   Mild ronal insufficiency and risk of congestive heart failure in men and women ≥70 years of age [J].
Chae, CU ;
Albert, CM ;
Glynn, RJ ;
Guralnik, JM ;
Curhan, GC .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (06) :682-686
[5]   ATRIAL-NATRIURETIC-FACTOR IN NORMAL SUBJECTS AND HEART-FAILURE PATIENTS - PLASMA-LEVELS AND RENAL, HORMONAL, AND HEMODYNAMIC-RESPONSES TO PEPTIDE INFUSION [J].
CODY, RJ ;
ATLAS, SA ;
LARAGH, JH ;
KUBO, SH ;
COVIT, AB ;
RYMAN, KS ;
SHAKNOVICH, A ;
PONDOLFINO, K ;
CLARK, M ;
CAMARGO, MJF ;
SCARBOROUGH, RM ;
LEWICKI, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) :1362-1374
[6]   Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment [J].
Coll, E ;
Botey, A ;
Alvarez, L ;
Poch, E ;
Quintó, L ;
Saurina, A ;
Vera, M ;
Piera, C ;
Darnell, A .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (01) :29-34
[7]   Role of diuretics in the prevention of heart failure - The antihypertensive and lipid-lowering treatment to prevent heart attack trial [J].
Davis, BR ;
Piller, LB ;
Cutler, JA ;
Furberg, C ;
Dunn, K ;
Franklin, S ;
Goff, D ;
Leenen, F ;
Mohiuddin, S ;
Papademetriou, V ;
Proschan, M ;
Ellsworth, A ;
Golden, J ;
Colon, P .
CIRCULATION, 2006, 113 (18) :2201-2210
[8]   The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction [J].
Dries, DL ;
Exner, DV ;
Domanski, MJ ;
Greenberg, B ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :681-689
[9]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[10]   Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease [J].
Eriksson, P ;
Deguchi, H ;
Samnegård, A ;
Lundman, P ;
Boquist, S ;
Tornvall, P ;
Ericsson, CG ;
Bergstrand, L ;
Hansson, LO ;
Ye, S ;
Hamsten, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (03) :551-557